A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

  • STATUS
    Recruiting
  • participants needed
    27
  • sponsor
    Eli Lilly and Company
Send
Updated on 19 February 2024
See if I qualify
body mass index
drug test

Summary

The main purpose of this study is to evaluate the safety of a study drug known as LY3209590 in Japanese participants with type 2 diabetes. Side effects and tolerability will be documented. Blood samples will be taken to compare how the body handles the drug and how it affects blood sugar levels. The study will last almost five months for each participant.

Details
Condition NIDDM
Age 20-74 years
Treatment LY3209590, Insulin Degludec
Clinical Study IdentifierNCT04276428
SponsorEli Lilly and Company
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Have type 2 diabetes mellitus (T2DM) for at least 1 year
Have received a stable daily dose of basal insulin at screening
Have hemoglobin A1c (HbA1c) greater than or equal to ()6.5 percent (%) and less than or equal to ()10.0% at screening
Have a body mass index greater than (>)18.5 and 40.0 kilograms per square meter (kg/m) at screening

Exclusion Criteria

Have received a total daily dose of insulin >1.2 units per kilogram (U/kg) of body weight at screening
Have received insulins except for basal insulins
Have received sulfonylurea at more than half of the maximum approved dose level
Have a history of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reaction or history of significant atopy
Have had more than 1 episode of severe hypoglycemia within 6 months before entry
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

body mass index
drug test

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.